{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:43:22Z","timestamp":1791315802998,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54-082973"],"award-info":[{"award-number":["U54-082973"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54-082973"],"award-info":[{"award-number":["U54-082973"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10875-019-00689-2","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T21:04:29Z","timestamp":1571259869000},"page":"786-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5700-6188","authenticated-orcid":false,"given":"Ami J.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sokolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumathi","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Scalchunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mangurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"issue":"1\u20133","key":"689_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12026-008-8084-3","volume":"44","author":"HD Ochs","year":"2009","unstructured":"Ochs HD. Mutations of the Wiskott Aldrich syndrome protein affect protein expression and dictate the clinical phenotypes. Immunol Res. 2009;44(1\u20133):84\u20138.","journal-title":"Immunol Res"},{"issue":"25","key":"689_CR2","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Maragoni F, Aiuti A, Villa AN, Grazia Roncarolo M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113(25):6288\u201395.","journal-title":"Blood."},{"issue":"6","key":"689_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00130832-200312000-00003","volume":"3","author":"K Imai","year":"2003","unstructured":"Imai K, Nonomaya S, Ochs HD. WASP (Wiskott Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol. 2003;3(6):427\u201336.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6 Pt1","key":"689_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott Aldrich syndrome. J Pediatr. 1994;125(6 Pt1):876\u201385.","journal-title":"J Pediatr"},{"issue":"6","key":"689_CR5","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","volume":"97","author":"AH Filopovich","year":"2001","unstructured":"Filopovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott Aldrich syndrome: collaborative study of the International Bone Marrow Transplantation Registry and the National Marrow Donor Program. Blood. 2001;97(6):1598\u2013603.","journal-title":"Blood."},{"issue":"1","key":"689_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","volume":"111","author":"Hulya Ozsahin","year":"2008","unstructured":"Ozsahin H, Cavazzano-Calvo M, Notorangelo LD, et al. Long-term outcome following hematopoietic stem cell transplantation in Wiskott Aldrich Syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008; 111(1):439\u2013445.","journal-title":"Blood"},{"issue":"11","key":"689_CR7","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/bmt.2012.31","volume":"47","author":"CR Shin","year":"2012","unstructured":"Shin CR, Kim MO, Li D, Bleesing JJ, Harris R, Mehta P, et al. Outcomes following hematopoietic stem cell transplantation for Wiskott Aldrich syndrome. Bone Marrow Transplant. 2012;47(11):1428\u201335.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"689_CR8","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.jaci.2018.06.042","volume":"142","author":"RA Elfeky","year":"2018","unstructured":"Elfeky RA, Furtado-Silva Chiesa R, et al. One hundred percent survival after transplantation of 34 patients with Wiskott Aldrich syndrome over 20 years. J Allergy Clin Immunol. 2018;142(5):1654\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"689_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","volume":"118","author":"D Moratto","year":"2011","unstructured":"Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011;118(6):1675\u201384.","journal-title":"Blood"},{"key":"689_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/13682820600691017","volume":"10","author":"MA Grootenhuis","year":"2007","unstructured":"Grootenhuis MA, Koopman HM, Verrips EGH, Vogels AGC, Last BF. Health\u2013related quality of life problems of children aged 8-11 years with chronic disease. Dev Neurorehabil. 2007;10:27\u201333.","journal-title":"Dev Neurorehabil"},{"key":"689_CR11","first-page":"43, 1","volume":"5","author":"JW Varni","year":"2007","unstructured":"Varni JW, Limbers CA, Burwinkle TM. Impaired health related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories\/severities utilizing the Peds QL\u2122 4.Generic Core scales. Health Qual Life Outcomes. 2007;5:43, 1\u201315.","journal-title":"Health Qual Life Outcomes"},{"key":"689_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2017.10.029","volume":"194","author":"V Barlogis","year":"2018","unstructured":"Barlogis V, Mahlaoui N, Auquier P, Fouyssac F, Pellier I, Vercasson C, et al. Burden of poor health conditioning and quality of life in 656 children with primary immunodeficiency. J Pediatr. 2018;194:211\u20137.","journal-title":"J Pediatr"},{"key":"689_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","volume":"37","author":"JW Varni","year":"1999","unstructured":"Varni JW, Seid M, Rode CA. The Peds QL\u2122 4.0: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126\u201339.","journal-title":"Med Care"},{"key":"689_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. Peds QL\u2122 4.0: reliability and validity of the pediatric quality of life inventory\u2122 version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800\u201312.","journal-title":"Med Care"},{"issue":"7","key":"689_CR15","first-page":"2090","volume":"94","author":"JW Varni","year":"2002","unstructured":"Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales. Multidimensional Fatigue Scale, and Cancer Module Cancer. 2002;94(7):2090\u2013106.","journal-title":"Multidimensional Fatigue Scale, and Cancer Module Cancer"},{"key":"689_CR16","doi-asserted-by":"publisher","first-page":"2 1","DOI":"10.1186\/1477-7525-5-21","volume":"5","author":"JW Varni","year":"2007","unstructured":"Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children\u2019s health-related quality of life: an analysis of 13,878 parents\u2019 reliability and validity across age subgroups using the Peds QL\u21224.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5:2 1\u201310.","journal-title":"Health Qual Life Outcomes"},{"key":"689_CR17","doi-asserted-by":"publisher","first-page":"55, 1","DOI":"10.1186\/1477-7525-2-55","volume":"2","author":"JW Varni","year":"2004","unstructured":"Varni JW, Sherman SA, Burwinkle TM, et al. The Peds QL\u2122 Family Impact Module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55, 1\u20136.","journal-title":"Health Qual Life Outcomes"},{"key":"689_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7525-7-32","volume":"7","author":"JA Panepinto","year":"2009","unstructured":"Panepinto JA, Hoffman RG, Pajewski NM. A psychometric evaluation of the Peds QL\u2122 Family Impact Module in parents of children with sickle cell disease. Health Qual Life Outcomes. 2009;7:32.","journal-title":"Health Qual Life Outcomes"},{"key":"689_CR19","unstructured":"Ware Je: SF-36 health survey: manual and interpretation guide Boston, MA The Health Institute; 1993."},{"key":"689_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF00433916","volume":"5","author":"DL Fairclough","year":"1996","unstructured":"Fairclough DL, Cella DF. Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions. Qual Life Res. 1996;5:321\u20139.","journal-title":"Qual Life Res"},{"key":"689_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11136-008-9350-5","volume":"17","author":"P Upton","year":"2008","unstructured":"Upton P, Lawford J, Eiser C. Parent-child agreement across child health related quality of life instruments: a review of the literature. Qual Life Res. 2008;17:895\u2013913.","journal-title":"Qual Life Res"},{"key":"689_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10875-012-9758-0","volume":"33","author":"T Cole","year":"2013","unstructured":"Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone hematopoetic stem cell transplant. J Clin Immunol. 2013;33:8\u201313.","journal-title":"J Clin Immunol"},{"key":"689_CR23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","volume":"139","author":"MT De la Morena","year":"2017","unstructured":"De la Morena MT, Leonard D, Torgerson TR, et al. Long term outcomes of 176 patients with X-linked hyper-IGM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139:1282\u201392.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-019-00689-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:24:25Z","timestamp":1602717865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-019-00689-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00689-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"25 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The opinions expressed are those of the authors and do not represent the position of the National Institute of Allergy and Infectious Diseases, the Office of Rare Diseases Research, the National Center for Advancing Translational Research, and the National Institutes of Health, of the US Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}